Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionCentral Bank & Trust Co
Latest Disclosed Ownership11,812 shares
Latest Disclosed Value $ 1,212,738
Central Bank & Trust Co reports 4.56% increase in ownership of ABL / Abbott Laboratories

On April 7, 2026 - Central Bank & Trust Co filed a 13F-HR form disclosing ownership of 11,812 shares of Abbott Laboratories (DE:ABL) valued at $1,049,142 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 9, 2026 disclosing 11,297 shares of Abbott Laboratories. This represents a change in shares of 4.56% during the quarter. The current value of the position is $888,499 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F ABBOTT LABS Equities 002824100 11,812 515 4.56 1,213 -14.35 0.1906
2026-01-09 2025-12-31 13F ABBOTT LABS Equities 002824100 11,297 -530 -4.48 1,415 -10.67 0.2189
2025-10-09 2025-09-30 13F ABBOTT LABS Equities 002824100 11,827 -307 -2.53 1,584 -4.00 0.2497
2025-07-09 2025-06-30 13F ABBOTT LABS Equities 002824100 12,134 -1,077 -8.15 1,650 -5.82 0.2698
2025-04-14 2025-03-31 13F ABBOTT LABS Equities 002824100 13,211 -928 -6.56 1,752 9.57 0.2928
2025-01-16 2024-12-31 13F ABBOTT LABS Equities 002824100 14,139 -72 -0.51 1,599 -1.30 0.2421
2024-10-30 2024-09-30 13F ABBOTT LABS Equities 002824100 14,211 -230 -1.59 1,620 8.00 0.2233
2024-07-19 2024-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 14,441 2,342 19.36 1,501 9.09 0.2086
2024-04-11 2024-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 12,099 143 1.20 1,375 4.56 0.1960
2024-01-09 2023-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 11,956 2,978 33.17 1,316 51.32 0.2040
2023-10-10 2023-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,978 417 4.87 869 -6.86 0.1512
2023-07-13 2023-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,561 -53 -0.62 933 7.00 0.1582
2023-04-13 2023-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,614 -159 -1.81 872 -9.45 0.1552
2023-01-18 2022-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,773 141 1.63 963 15.33 0.1817
2022-10-20 2022-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,632 4,386 103.30 835 81.13 0.1795
2022-07-22 2022-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 4,246 2,867 207.90 461 182.82 0.0940
2022-04-18 2022-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 1,379 706 104.90 163 71.58 0.0260
2022-01-18 2021-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 673 0 0.00 95 18.75 0.0147
2021-10-19 2021-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 673 56 9.08 80 11.11 0.0131
2021-07-16 2021-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 617 -253 -29.08 72 -30.77 0.0116
2021-04-20 2021-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 870 -6,999 -88.94 104 -87.94 0.0177
2021-01-12 2020-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 7,869 -184 -2.28 862 -1.60 0.1489
2020-10-08 2020-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,053 1 0.01 876 19.02 0.1640
2020-07-15 2020-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 8,052 2,411 42.74 736 65.39 0.1453
2020-04-14 2020-03-31 13F/A-1 ABBOTT LABORATORIES COMMON STOCK 002824100 5,641 -444 -7.30 445 -15.88 0.1071
2020-04-14 2020-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 4,671 -1,414 393 64,672.9409
2020-01-13 2019-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 6,085 1,065 21.22 529 25.95 0.1045
2019-10-23 2019-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 5,020 349 7.47 420 6.87 0.0903
2019-07-16 2019-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 4,671 -657 -12.33 393 -7.75 0.0885
2019-04-22 2019-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 5,328 -5,582 -51.16 426 -46.01 0.0956
2019-01-17 2018-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 10,910 -1,010 -8.47 789 -9.73 0.1990
2018-11-23 2018-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 11,920 635 5.63 874 27.03 0.2021
2018-07-17 2018-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 11,285 3,055 37.12 688 39.55 0.1713
2018-04-27 2018-03-31 13F ABBOTT LABORATORIES LARGE CAP - STOCKS 002824100 8,230 1,635 24.79 493 31.12 0.1231
2018-01-16 2017-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 6,595 4,762 259.79 376 283.67 0.0907
2017-10-13 2017-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 1,833 -225 -10.93 98 -2.00 0.0244
2017-07-11 2017-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 2,058 -145 -6.58 100 2.04 0.0260
2017-04-28 2017-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 2,203 0 0.00 98 15.29 0.0254
2017-01-20 2016-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 2,203 0 0.00 85 -8.60 0.0227
2016-10-07 2016-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 2,203 0 0.00 93 6.90 0.0261
2016-07-11 2016-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 2,203 -989 -30.98 87 -34.59 0.0250
2016-04-11 2016-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 3,192 -265 -7.67 133 -14.19 0.0371
2016-01-12 2015-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 3,457 -263 -7.07 155 3.33 0.0448
2015-10-13 2015-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 3,720 650 21.17 150 -0.66 0.0495
2015-07-30 2015-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 3,070 1,253 68.96 151 77.65 0.0480
2015-04-21 2015-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 1,817 1,817 0.00 85 0.0283
2015-01-27 2014-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 0 -1,017 -100.00 0 -100.00
2014-10-16 2014-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 1,017 739 265.83 42 281.82 0.0159
2014-09-11 2014-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 278 -44 -13.66 11 -15.38 0.0043
2014-04-07 2014-03-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 322 44 15.83 13 18.18 0.0051
2014-03-13 2013-12-31 13F ABBOTT LABORATORIES COMMON STOCK 002824100 278 -22 -7.33 11 10.00 0.0043
2013-10-30 2013-09-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 300 0 0.00 10 -99.91 0.0045
2013-07-09 2013-06-30 13F ABBOTT LABORATORIES COMMON STOCK 002824100 300 300 11,464 0.0054
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.